Okyo PharmaOKYO
13F holders, Q3 2024 (September 30)6holders −1
1new positions
2sold out
1famous investor
$1.02avg. 13F price*
At the end of Q3 2024, 6 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 2 sold out. The largest holders were Barclays PLC ($980K), Citadel Advisors ($15K) and Cerity Partners LLC ($13K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $15K |
| Exits | 2 | $34K |
All 13F filers, Q2 2024 → Q3 2024: 14,876 shares bought and 24,435 shares sold, net −9,559 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Barclays PLC | 0.00% | No change | 961,000 | $980K |
| Citadel Advisors | 0.00% | New | 14,876 | $15K |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $13K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $12K |
| UBS Group AG | 0.00% | Reduce -72.4% | 525 | $536 |
| Continuum Advisory, LLC | 0.00% | No change | 50 | $53 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.